278 related articles for article (PubMed ID: 27543977)
1. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.
Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
[TBL] [Abstract][Full Text] [Related]
2. MAGI-2 in prostate cancer: an immunohistochemical study.
Goldstein J; Borowsky AD; Goyal R; Roland JT; Arnold SA; Gellert LL; Clark PE; Hameed O; Giannico GA
Hum Pathol; 2016 Jun; 52():83-91. PubMed ID: 26980016
[TBL] [Abstract][Full Text] [Related]
3. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic biomarkers of prostate cancer.
Häggarth L; Hägglöf C; Jaraj SJ; Wester K; Pontén F; Ostman A; Egevad L
Scand J Urol Nephrol; 2011 Feb; 45(1):60-7. PubMed ID: 21034352
[TBL] [Abstract][Full Text] [Related]
5. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319
[TBL] [Abstract][Full Text] [Related]
7. Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?
Yamada H; Tsuzuki T; Maeda N; Yamauchi Y; Yoshida S; Ishida R; Nishikimi T; Yokoi K; Kobayashi H
Prostate; 2013 Jan; 73(1):54-9. PubMed ID: 22593005
[TBL] [Abstract][Full Text] [Related]
8. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
9. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
10. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
[TBL] [Abstract][Full Text] [Related]
11. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens.
Helpap B
Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
Hameed O; Sublett J; Humphrey PA
Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity and specificity of AMACR expression in diagnosis of prostatic carcinoma].
Sheng YH; Jiang ZM; Zhang HZ; Zhou JH; Liu L
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):687-8. PubMed ID: 18194603
[No Abstract] [Full Text] [Related]
14. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.
Santinelli A; Mazzucchelli R; Barbisan F; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Am J Clin Pathol; 2007 Oct; 128(4):657-66. PubMed ID: 17875519
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
Shah RB; Tadros Y; Brummell B; Zhou M
Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
[TBL] [Abstract][Full Text] [Related]
17. Alpha-methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies.
Evans AJ
J Clin Pathol; 2003 Dec; 56(12):892-7. PubMed ID: 14645345
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
19. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.
Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z
Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336
[TBL] [Abstract][Full Text] [Related]
20. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
